Lupin, based in India, has been granted approval to manufacture eight oral strengths of the generic formulation.
Related Articles on Pain Management:
myoscience Receives FDA Clearance for Pain Management Device
Pain Management Specialist Dr. John Keel Joins New England Baptist Hospital
Opposition Threatens Kentucky Drug Abuse Bill
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.